Showing 1 - 10 of 936
The paper discusses two types of problems related to assigning or denying intellectual property rights to agro-biotechnological innovations in the relation between developed and developing countries. First, protecting property rights on innovations creates incentives towards further research and...
Persistent link: https://www.econbiz.de/10014064207
Fledgling efforts exist to establish open-source projects in biotechnology. Following copyleft, participants agree that … for the public benefit. In addition, although open source biotechnology may decrease some downstream economic rewards, it …
Persistent link: https://www.econbiz.de/10014071830
British biotechnology companies we have identified all patents filed at the European Patent Office (EPO). Applying hazard rate …
Persistent link: https://www.econbiz.de/10003861082
British biotechnology companies we have identified all patents filed at the European Patent Office (EPO). Applying hazard rate …
Persistent link: https://www.econbiz.de/10003848824
Today it is widely recognized that biotechnology is one of the key sectors of the emerging knowledge based economy (see …, e.g., Trippl and Tödtling 2007). Revenues and turnovers from biotechnology applications – here defined to include all … considerably, in particular over the last two decades. A specific property of the biotechnology industry is its knowledge …
Persistent link: https://www.econbiz.de/10014141411
This study examined how intangible assets of Japanese biotechnology startups affected their intention to go public at …
Persistent link: https://www.econbiz.de/10013091541
property as a package) could be used as an institution to facilitate technology transactions in biotechnology. Patent pools … have been used with success in the consumer electronics and other sectors but they are untested in biotechnology despite … this industry. The first is that the current antitrust requirements are difficult to meet in biotechnology. The second is …
Persistent link: https://www.econbiz.de/10014206748
policy, with a focus on biotechnology, held by the OECD's Competition Committee at the OECD in June 2004. The roundtable … enforcement issues, and the interface between IP and competition policy in the context of the biotechnology industry. This …
Persistent link: https://www.econbiz.de/10014066461
We have examined all the US patents (444) issued to homegrown Indian pharma and pharma biotech firms. Most (425, 95%) patents are pharma patents not biotech (19). Also, only 11 patents have been cited ten times or more. This data provides one snapshot of the biotech industry in India today. It...
Persistent link: https://www.econbiz.de/10014129813
Persistent link: https://www.econbiz.de/10010491010